Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ABT | Common shares without par value | Options Exercise | $936K | +15.8K | +19.39% | $59.42 | 97K | Oct 26, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ABT | Option (right to buy) | Options Exercise | $0 | -15.8K | -100% | $0.00* | 0 | Oct 26, 2021 | Common Shares | 15.8K | $59.42 | Direct | F1 |
Id | Content |
---|---|
F1 | Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |